Institutional
NEXTBio Capital Management LP
CIK 0002038158
$215.4M
Reported AUM
24
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · NEXTBio Capital Management LP · Q1 2026
AI · grounded in 13F
NEXTBio Capital Management LP increased its stake in CMPS by 168.58%. The fund also established a new position in SMMT valued at $1.7M and grew its holding in RYTM by 86.54%. Conversely, the manager trimmed its position in CMPX by 23.86%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $31.9M | 14.80% | +53,344 | +9.7% |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | $97.38 | -5.26% | 79.07% | 97.01% | $24.2M | 11.24% | — | HELD |
| 3 | STTK | SHATTUCK LABS INC | $4.58 | -4.58% | 301.75% | -79.22% | $20.3M | 9.40% | — | HELD |
| 4 | VOR | VOR BIOPHARMA INC | $13.16 | -8.10% | 193.75% | -94.74% | $17.8M | 8.28% | — | HELD |
| 5 | CMPS | COMPASS PATHWAYS PLC | $12.11 | -7.20% | 152.29% | -65.87% | $11.2M | 5.19% | +1,268,776 | +168.6% |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | $86.40 | -1.38% | 26.85% | 399.71% | $11.0M | 5.09% | +58,492 | +86.5% |
| 7 | XENE | XENON PHARMACEUTICALS INC | $51.73 | -2.38% | 63.50% | 199.54% | $10.7M | 4.95% | −479 | −0.3% |
| 8 | PVLA | PALVELLA THERAPEUTICS INC NE | $108.67 | -5.36% | 327.83% | -60.97% | $10.3M | 4.79% | — | HELD |
| 9 | ZBIO | ZENAS BIOPHARMA INC | $17.47 | -4.95% | 57.10% | -17.73% | $8.3M | 3.87% | +104,753 | +32.5% |
| 10 | IVA | INVENTIVA SA | $4.03 | -4.73% | 11.79% | -70.01% | $7.4M | 3.44% | +34,783 | +2.7% |
| 11 | VSTM | VERASTEM INC | $3.71 | -3.89% | -42.21% | -90.43% | $6.9M | 3.22% | −530 | −0.0% |
| 12 | CBIO | CRESCENT BIOPHARMA INC. | $18.00 | -2.44% | -5.26% | -108.10% | $6.8M | 3.18% | — | HELD |
| 13 | ORIC | ORIC PHARMACEUTICALS INC | $7.50 | -6.48% | -19.53% | -54.95% | $6.6M | 3.08% | −92,101 | −15.0% |
| 14 | GPCR | STRUCTURE THERAPEUTICS INC | $37.58 | -3.79% | 77.85% | 57.97% | $6.4M | 2.98% | +38,796 | +41.1% |
| 15 | PCVX | VAXCYTE INC | $47.36 | -2.87% | 28.03% | 118.45% | $5.5M | 2.57% | −262 | −0.3% |
| 16 | COGT | COGENT BIOSCIENCES INC | $31.02 | -5.40% | 356.18% | 417.00% | $5.0M | 2.34% | +35,369 | +36.9% |
| 17 | CMPX | COMPASS THERAPEUTICS INC | $2.04 | -4.23% | -18.40% | -58.37% | $4.5M | 2.08% | −265,801 | −23.9% |
| 18 | EVMN | EVOMMUNE INC | $19.92 | -3.72% | 8.20% | 16.36% | $4.2M | 1.96% | −44,223 | −19.4% |
| 19 | OCS | OCULIS HOLDING AG | $11.21 | -5.24% | -43.72% | 16.05% | $4.0M | 1.85% | −158 | −0.1% |
| 20 | ZLAB | ZAI LAB LTD | $16.62 | -4.15% | -56.39% | -88.51% | $3.4M | 1.60% | +20,000 | +12.2% |
| 21 | IRON | DISC MEDICINE INC | $67.00 | -5.78% | 33.95% | -45.13% | $3.4M | 1.56% | +9,877 | +23.1% |
| 22 | KALV | KALVISTA PHARMACEUTICALS INC | $26.95 | 0.00% | 87.61% | 33.81% | $2.7M | 1.23% | — | HELD |
| 23 | SMMT | SUMMIT THERAPEUTICS INC | $14.77 | -0.47% | -28.27% | 101.50% | $1.7M | 0.79% | +89,717 | NEW |
| 24 | ACET | ADICET BIO INC | $7.26 | -10.92% | -40.06% | -93.87% | $1.1M | 0.50% | — | HELD |
Source: SEC EDGAR · accession 0001172661-26-001957. 13F discloses long positions only — shorts, foreign equities, and options are excluded.